Ethical business practice In the Psychedelic space

We’re witnessing an electrifying new wave of groundbreaking advancements in psychedelics-based therapies and treatment. As a sector with countless potential applications in the health and wellness industry, this movement carries with it an assortment of commercial opportunities: from medicinal supply chain, to private clinics, to capital investment from every angle.

In the spirit of psychedelic medicine and the holistic qualities at its core, it is vital that the research and treatment applications be protected from the vices of standard corporate practice.

 The North Star pledge has been proposed as an ethical beacon to help maintain compassion and integrity in the development and practice of psychedelic-assisted therapies. In this webinar, we’ll go deep into the ethical responsibilities of the psychedelic therapeutics movement, particularly where it interfaces with business. PsyTech is proud to host an exceptional panel of industry leaders for this important discussion.

Meet the Experts

Liana Sananda Gillooly

Liana Gillooly

Founder/Development Officer at North Star / MAPS


David Nikzad

Founder Orthogonal Thinker Inc/EI.Ventures

Stacey Wallin

Stacey Wallin

Co-Founder and Chief Strategy Officer at Numinus Wellness Inc

Dick Simon

Dick Simon

Chairman, Advisory Council Center for the Neuroscience of Psychedelics, Massachusetts General Hospital

Guy Lieberman

Guy Lieberman, Moderator

Director of Nahana Foundation